Effect of methionine oxidation on the structural properties, conformational stability, and aggregation of immunoglobulin light chain LEN

Biochemistry

Volumn 47, Issue 33, 2008, Pages 8665-8677

  Hu, Dongmei ^a   Qin, Zhijie ^a   Xue, Bin ^b   Fink, Anthony L ^a   Uversky, Vladimir N ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INSTITUTE FOR BIOLOGICAL INSTRUMENTATION   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

AGGLOMERATION; OXIDATION;

AGGREGATION BEHAVIORS; CONFORMATIONAL STABILITIES; IN-VITRO; LIGHT CHAIN; METHIONINE OXIDATION; MULTIPLE MYELOMA; NATIVE STATES; RENAL DYSFUNCTION; STRUCTURAL CHANGES; STRUCTURAL PROPERTIES;

CHEMICAL OXYGEN DEMAND;

IMMUNOGLOBULIN LIGHT CHAIN; METHIONINE;

ARTICLE; IMMUNOGLOBULIN AGGREGATE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN STRUCTURE;

HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; IMMUNOGLOBULIN VARIABLE REGION; METHIONINE; MODELS, MOLECULAR; OXIDATION-REDUCTION; PROTEIN CONFORMATION; TIME FACTORS;

EID: 49849100536     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi800806d     Document Type: Article

References (58)

1. Glenner, G. G. (1980) Amyloid deposits and amyloidosis. The β-fibrilloses (first of two parts). N. Engl. J. Med. 302, 1283-1292.
2. Sipe, J. D. (1992) Amyloidosis. Annu. Rev. Biochem. 61, 947-975.
3. Uversky, V. N.; Talapatra, A.; Gillespie, J. R.; Fink, A. L. (1999)Protein deposits as the molecular basis of amyloidosis. I. Systemic amyloidoses. Med. Sci. Monit. 5.
4. Uversky, V. N., Talapatra, A., Gillespie, J. R., and Fink, A. L. (1999) Protein Deposits As the Molecular Basis of Amyloidosis. II. Localized Amyloidosis and Neurodegenerative Disorders. Med. Sci. Monit. 5, 1238-1254.
5. Uversky, V. N., and Fink, A. L. (2004) Conformational constraints for amyloid fibrillation: The importance of being unfolded. Biochim. Biophys. Acta 1698, 131-153.
6. Kelly, J. W. (1998) The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. Curr. Opin. Struct. Biol. 8, 101-106.
7. Dobson, C. M. (1999) Protein misfolding, evolution and disease. Trends Biochem. Sci. 24, 329-332.
8. Bellotti, V., Mangione, P., and Stoppini, M. (1999) Biological activity and pathological implications of misfolded proteins. Cell. Mol. Life Sci. 55, 977-991.
9. Rochet, J. C., and Lansbury, P. T., Jr. (2000) Amyloid fibrillogenesis: Themes and variations. Curr. Opin. Struct. Biol. 10, 60-68.
10. Lansbury, P. T., Jr. (1999) Evolution of amyloid: What normal protein folding may tell us about fibrillogenesis and disease. Proc. Natl. Acad. Sci. U.S.A. 96, 3342-3344.
11. Fink, A. L. (1998) Protein aggregation: Folding aggregates, inclusion bodies and amyloid. Folding Des. 3, R9-R23.
12. Dobson, C. M. (2001) The structural basis of protein folding and its links with human disease. Philos. Trans. R. Soc. London, Ser. B 356, 133-145.
13. Zerovnik, E. (2002) Amyloid-fibril formation. Proposed mechanisms and relevance to conformational disease. Eur. J. Biochem. 269, 3362-3371.
14. Harper, J. D., Wong, S. S., Lieber, C. M., and Lansbury, P. T., Jr. (1999) Assembly of Aβ amyloid protofibrils: An in vitro model for a possible early event in Alzheimer's disease. Biochemistry 38, 8972-8980.
15. Uversky, V. N., Lee, H. J., Li, J., Fink, A. L., and Lee, S. J. (2001) Stabilization of partially folded conformation during α-synuclein oligomerization in both purified and cytosolic preparations. J. Biol. Chem. 276, 43495-43498.
16. Uversky, V. N., Li, J., and Fink, A. L. (2001) Evidence for a partially folded intermediate in α-synuclein fibril formation. J. Biol. Chem. 276, 10737-10744.
17. Gallo, G., Picken, M., Buxbaum, J., and Frangione, B. (1989) The spectrum of monoclonal immunoglobulin deposition disease associated with immunocytic dyscrasias. Semin. Hematol. 26, 234-245.
18. Buxbaum, J. (1992) Mechanisms of disease: Monoclonal immunoglobulin deposition. Amyloidosis, light chain deposition disease, and light and heavy chain deposition disease. Hematol. Oncol. Clin. North Am. 6, 323-346.
19. Solomon, A., Weiss, D. T., and Pepys, M. B. (1992) Induction in mice of human light-chain-associated amyloidosis. Am. J. Pathol. 140, 629-637.
20. Solomon, A. (1986) Clinical implications of monoclonal light chains. Semin. Oncol. 13, 341-349.
21. Solomon, A. (1985) Light chains of human immunoglobulins. Methods Enzymol. 116, 101-121.
22. Kaplan, B., Vidal, R., Kumar, A., Ghiso, J., Frangione, B., and Gallo, G. (1997) Amino-terminal identity of co-existent amyloid and non-amyloid immunoglobulin κ light chain deposits. A human disease to study alterations of protein conformation. Clin. Exp. Immunol. 110, 472-478.
23. Sanders, P. W., and Booker, B. B. (1992) Pathobiology of cast nephropathy from human Bence Jones proteins. J. Clin. Invest. 89, 630-639.
24. Raffen, R., Dieckman, L. J., Szpunar, M., Wunschl, C., Pokkuluri, P. R., Dave, P., Wilkins Stevens, P., Cai, X., Schiffer, M., and Stevens, F. J. (1999) Physicochemical consequences of amino acid variations that contribute to fibril formation by immunoglobulin light chains. Protein Sci. 8, 509-517.
25. Pokkuluri, P. R., Raffen, R., Dieckman, L., Boogaard, C., Stevens, F. J., and Schiffer, M. (2002) Increasing protein stability by polar surface residues: Domain-wide consequences of interactions within a loop. Biophys. J. 82, 391-398.
26. Kabat, E. A., Wu, T. T., Perry, H. M., Gottesman, K. S., and Foeller, C. (1991) Sequences of Proteins of Immunological Interest, 5th ed., NIH Publication 91-3242, U.S. Department of Health and Human Services, U.S. Government Printing Office, Washington, DC.
27. Huang, D. B., Chang, C. H., Ainsworth, C., Johnson, G., Solomon, A., Stevens, F. J., and Schiffer, M. (1997) Variable domain structure of κIV human light chain Len: High homology to the murine light chain McPC603. Mol. Immunol. 34, 1291-1301.
28. Stevens, P. W., Raffen, R., Hanson, D. K., Deng, Y. L., Berrios-Hammond, M., Westholm, F. A., Murphy, C., Eulitz, M., Wetzel, R., Solomon, A., et al. (1995) Recombinant immunoglobulin variable domains generated from synthetic genes provide a system for in vitro characterization of light-chain amyloid proteins. Protein Sci. 4, 421-432.
29. Souillac, P. O., Uversky, V. N., Millett, I. S., Khurana, R., Doniach, S., and Fink, A. L. (2002) Effect of association state and conformational stability on the kinetics of immunoglobulin light chain amyloid fibril formation at physiological pH. J. Biol. Chem. 277, 12657-12665.
30. Souillac, P. O., Uversky, V. N., Millett, I. S., Khurana, R., Doniach, S., and Fink, A. L. (2002) Elucidation of the molecular mechanism during the early events in immunoglobulin light chain amyloid fibrillation. Evidence for an off-pathway oligomer at acidic pH. J. Biol. Chem. 277, 12666-12679.
31. Souillac, P. O., Uversky, V. N., and Fink, A. L. (2003) Structural transformations of oligomeric intermediates in the fibrillation of the immunoglobulin light chain LEN. Biochemistry 42, 8094-8104.
32. Khurana, R., Gillespie, J. R., Talapatra, A., Minert, L. J., Ionescu-Zanetti, C., Millett, I., and Fink, A. L. (2001) Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates. Biochemistry 40, 3525-3535.
33. Stadtman, E. R., and Levine, R. L. (2000) Protein oxidation. Ann. N.Y. Acad. Sci. 899, 191-208.
34. Stadtman, E. R. (2001) Protein oxidation in aging and age-related diseases. Ann. N.Y. Acad. Sci. 928, 22-38.
35. Vogt, W. (1995) Oxidation of methionyl residues in proteins: Tools, targets, and reversal. Free Radical Biol. Med. 18, 93-105.
36. Moskovitz, J., Bar-Noy, S., Williams, W. M., Requena, J., Berlett, B. S., and Stadtman, E. R. (2001) Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals. Proc. Natl. Acad. Sci. U.S.A. 98, 12920-12925.
37. Levine, R. L., Moskovitz, J., and Stadtman, E. R. (2000) Oxidation of methionine in proteins: Roles in antioxidant defense and cellular regulation. IUBMB Life 50, 301-307.
38. Peng, K., Radivojac, P., Vucetic, S., Dunker, A. K., and Obradovic, Z. (2006) Length-dependent prediction of protein intrinsic disorder. BMC Bioinf. 7, 208.
39. Prilusky, J., Felder, C. E., Zeev-Ben-Mordehai, T., Rydberg, E. H., Man, O., Beckmann, J. S., Silman, I., and Sussman, J. L. (2005) FoldIndex: A simple tool to predict whether a given protein sequence is intrinsically unfolded. Bioinformatics 21, 3435-3438.
40. Romero, P., Obradovic, Z., Li, X., Garner, E. C., Brown, C. J., and Dunker, A. K. (2001) Sequence complexity of disordered protein. Proteins 42, 38-48.
41. Uversky, V. N., Gillespie, J. R., and Fink, A. L. (2000) Why are "natively unfolded" proteins unstructured under physiologic conditions? Proteins 41, 415-427.
42. Naiki, H., Higuchi, K., Hosokawa, M., and Takeda, T. (1989) Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1. Anal. Biochem. 177, 244-249.
43. Sreerama, N., Manning, M. C., Powers, M. E., Zhang, J. X., Goldenberg, D. P., and Woody, R. W. (1999) Tyrosine, phenylalanine, and disulfide contributions to the circular dichroism of proteins: Circular dichroism spectra of wild-type and mutant bovine pancreatic trypsin inhibitor. Biochemistry 38, 10814-10822.
44. Ptitsyn, O. B. (1995) Molten globule and protein folding. Adv. Protein Chem. 47, 83-229.
45. Semisotnov, G. V., Rodionova, N. A., Razgulyaev, O. I., Uversky, V. N., Gripas, A. F., and Gilmanshin, R. I. (1991) Study of the "molten globule" intermediate state in protein folding by a hydrophobic fluorescent probe. Biopolymers 31, 119-128.
46. Altschul, S. F., Madden, T. L., Schaffer, A. A., Zhang, J., Zhang, Z., Miller, W., and Lipman, D. J. (1997) Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res. 25, 3389-3402.
47. Benhar, I., and Pastan, I. (1995) Identification of residues that stabilize the single-chain Fv of monoclonal antibodies B3. J. Biol. Chem. 270, 23373-23380.
48. Gassner, N. C., Baase, W. A., and Matthews, B. W. (1996) A test of the "jigsaw puzzle" model for protein folding by multiple methionine substitutions within the core of T4 lysozyme. Proc. Natl. Acad. Sci. U.S.A. 93, 12155-12158.
49. Sickmeier, M., Hamilton, J. A., LeGall, T., Vacic, V., Cortese, M. S., Tantos, A., Szabo, B., Tompa, P., Chen, J., Uversky, V. N., Obradovic, Z., and Dunker, A. K. (2007) DisProt: The Database of Disordered Proteins. Nucleic Acids Res. 35, D786-D793.
50. Vucetic, S., Brown, C. J., Dunker, A. K., and Obradovic, Z. (2003) Flavors of protein disorder. Proteins 52, 573-584.
51. Uversky, V. N. (2008) Amyloidogenesis of natively unfolded proteins. Curr. Alzheimer's Res. 5, 260-287.
52. Sunde, M., and Blake, C. (1997) The structure of amyloid fibrils by electron microscopy and X-ray diffraction. Adv. Protein Chem. 50, 123-159.
53. Walsh, D. M., Lomakin, A., Benedek, G. B., Condron, M. M., and Teplow, D. B. (1997) Amyloid β-protein fibrillogenesis. Detection of a protofibrillar intermediate. J. Biol. Chem. 272, 22364-22372.
54. Kisilevsky, R. (2000) Review: Amyloidogenesis-unquestioned answers and unanswered questions. J. Struct. Biol. 130, 99-108.
55. Gallo, G., Goni, F., Boctor, F., Vidal, R., Kumar, A., Stevens, F. J., Frangione, B., and Ghiso, J. (1996) Light chain cardiomyopathy. Structural analysis of the light chain tissue deposits. Am. J. Pathol. 148, 1397-1406.
56. Stokes, M. B., Jagirdar, J., Burchstin, O., Kornacki, S., Kumar, A., and Gallo, G. (1997) Nodular pulmonary immunoglobulin light chain deposits with coexistent amyloid and nonamyloid features in an HIV-infected patient. Mod. Pathol. 10, 1059-1065.
57. Qin, Z., Hu, D., Zhu, M., and Fink, A. L. (2007) Structural characterization of the partially folded intermediates of an immunoglobulin light chain leading to amyloid fibrillation and amorphous aggregation. Biochemistry 46, 3521-3531.
58. Humphrey, W., Dalke, A., and Schulten, K. (1996) VMD: visual molecular dynamics. J. Mol. Graphics 14, 33-38, 27-38.